Roles of Host Nonhematopoietic Cells in Autoimmunity and Donor Cell Engraftment in Graft-versus-host Disease |
Kim, Ju-Yang
(Biomedical Research Center, Ulsan University Hospital, School of Medicine, University of Ulsan)
Park, So-Hye (School of Biological Sciences, University of Ulsan) Kim, Hyun-A (School of Biological Sciences, University of Ulsan) Jung, Dae-Hee (School of Biological Sciences, University of Ulsan) Kim, Hyun-Ju (School of Biological Sciences, University of Ulsan) Choi, Hye-Jeong (Department of Pathology, Ulsan University Hospital, School of Medicine, University of Ulsan) Cho, Hong-Rae (Biomedical Research Center, Ulsan University Hospital, School of Medicine, University of Ulsan) Kwon, Byung-Suk (Biomedical Research Center, Ulsan University Hospital, School of Medicine, University of Ulsan) |
1 | Korngold R, Sprent J: Features of T cells causing H-2-restricted lethal graft-vs-host disease across minor histocompatibility barriers. J Exp Med 155:872-883, 1982 DOI ScienceOn |
2 | Reddy P, Teshima T, Kukuruga M, Ordemann R, Liu C, Lowler K, Ferrara JL: Interleukin-18 regulates acute graftversus- host disease by enhancing Fas-mediated donor T cell apoptosis. J Exp Med 194;1433-1440, 2001 DOI ScienceOn |
3 | Brown GR, Lee E, Thiele DL: TNF-TNFR2 interactions are critical for the development of intestinal graft-versus-host disease in MHC class II disparate (C57BL/6JC57BL/6J bm12)F1 mice. J Immunol 168;3065-3071, 2002 DOI |
4 | Gonzalez M, Quezada SA, Blazar BR, Panoskaltsis-Mortari A, Rudensky AY, Noelle RJ: The balance between donor T cell anergy and suppression versus lethal graft-versus- host disease is determined by host conditioning. J Immunol 169;5581-5589, 2002 DOI |
5 | Kim J, Kim HJ, Park K, Kim J, Choi HJ, Yagita H, Nam SK, Cho HR, Kwon B: Costimulatory molecule-targeted immunotherapy of chronic graft-versus-host disease. Blood 110;776-782, 2007 DOI ScienceOn |
6 | Kim W, Kim J, Jung D, Kim H, Choi HJ, Cho HR, Kwon B: Induction of lethal graft-versus-host disease by anti- CD137 monoclonal antibody in mice prone to chronic GVHD. Biol Blood Marrow Transplant 15;306-314, 2009 DOI ScienceOn |
7 | Rouquette-Gally AM, Boyeldieu D, Gluckman E, Abuaf N, Combrisson A: Autoimmunity in 28 patients after allogeneic bone marrow transplantation: comparison with Sjogren syndrome and scleroderma. Br J Haematol 66;45-47, 1987 DOI |
8 | Rouquette-Gally AM, Boyeldieu D, Prost AC, Gluckman E: Autoimmunity after allogeneic bone marrow transplantation. A study of 53 long-term-surviving patients. Transplantation 46;238-240, 1988 DOI ScienceOn |
9 | Sherer Y, Shoenfeld Y: Autoimmune disease and autoimmunity post-bone marrow transplantation. Bone Marrow Transplant 22;873-881, 1998 DOI ScienceOn |
10 | Tivol E, Komorowski R, Drobyski WR: Emergent autoimmuity in graft-versus-host disease. Blood 105;4885-4891, 2005 DOI ScienceOn |
11 | Horowitz JB, Kaye J, Katz ME, Janeway CA Jr: Ability of fixed B-lymphoma cells to present foreign protein antigen graftments and allogeneic MHC molecules to a cloned helper- T cell line. Cell Immunol 109:429-436, 1987 DOI ScienceOn |
12 | Shlomchik WD, Couzens MS, Tang CB, McNiff J, Robert ME, Liu J, Shlomchik MJ, Emerson SG: Prevention of graft versus host disease by inactivation of host antigen presenting cells. Science 285:412-415, 1999 DOI ScienceOn |
13 | Zhang Y, Hexner E, Frank D, Emerson SG. T cells de novo from donor hemopoietic stem cells mediate the evolution from acute to chronic graft-versus-host disease. J Immunol 179;3305-3314, 2007 DOI |
14 | Song HK, Noirchashm H, Lieu YK, Rostani S, Greeley SA, Barker CF, Naji A: Cutting edge: alloimmune responses against major and minor histocompatibility antigens: distinct division kinetics and requirement for CD28 costimulation. J Immunol 162;2467-2471, 1999 |
15 | Benichou G, Takizawa PA, Olson CA, McMillian M, Secarz EE: Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection. J Exp Med 175:305-308, 1992 DOI ScienceOn |
16 | Liu Z, Braunstein NS, Suciu-Foca N: T cell recognition of allopeptides in context of syngeneic MHC. J Immunol 148; 35-40, 1992 |
17 | Matte CC, Liu J, Anderson BE, Athanasiadis I, Jain D, McNiff J, Shlomchik WD: Donor APCs are required for maximal GVHD but not for GVL. Nat Med 10;987-992, 2004 DOI ScienceOn |
18 | Cooke KR, Hill GR, Crawford JM, Bungard D, Brinson YS, Delmonte J Jr, Ferrara JL: Tumor necrosis factor-alpha production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease. J Clin Invest 102;1882-1891, 1998 DOI ScienceOn |
19 | Krijianouski OI, Hill GR, Cooke KR, Teshima T, Crawford JM, Brinson YS, Ferrara JL: Keratinocyte growth factor separates graft-versus-leukemia effects from graft-versushost disease. Blood 94;825-831, 1999 |
20 | Aosai F, Ohlen C, Ljunggren HG, Hoqlund P, Franksson L, Ploegh H, Towsend A, Karre K, Stauss HJ: Different types of allospecific CTL clones identified by their ability to recognize peptide loading-defective target cells. Eur J Immunol 21;2767-2774, 1991 DOI ScienceOn |
21 | Man S, Saler RD, Engelhard VH: Role of endogenous peptide in human alloreactive cytotoxic T cell responses. Int Immunol 4;367-375, 1992 DOI ScienceOn |
22 | Crumpacker DB, Alexander J, Cresswell P, Engelhard VH: Role of endogenous peptides in murine allogeneic cytotoxic T cell responses assessed using transfectants of theantigen- processing mutant 174CEM.T2. J Immunol 148; 3004-3011, 1992 |
23 | Cooke KR, Krenger W, Martin TR, Kobzik L, Brewer J, Simmons R, Crawford JM, van den Brink MR, Ferra JL: Host reactive donor T cells are associated with lung injury after experimental allogeneic bone marrow transplantation. Blood 92;2571-2580, 1998 |
24 | Teshima T, Ordemann R, Reddy P, Gagins S, Liu C, Cooke KR, Ferrara JL: Acute graft-vs-host disease does not required alloantigen expression on host epithelium. Nat Med 8:575-581, 2002 DOI ScienceOn |
25 | Kim J, Choi WS, Kim HJ, Kwon B. Prevention of chronic graft-versus-host disease by stimulation with glucocorticoid- induced TNF receptor. Exp Mol Med 38;94-99, 2006 DOI |
26 | Kim J, Kim HJ, Choi WS, Cho HR, Kwon B. Maintenance of T-cell anergy by regulatory T cells. Exp Mol Med 38;494-501, 2006 DOI ScienceOn |
27 | Hill GR, Crawford JM, Cooke KR, Brinson YS, Pal L, Ferrara JL: Total body irradiation effects on acute graft versus host disease: the role of gastrointestinal damage and inflammatory cytokines. Blood 90;3204-3213, 1997 |
28 | Jones SC, Murphy GF, Friedman TM, Korngold R: Importance of donor histocompatibility antigen expression by nonhematopoietic tissues in a T cell mediated graft-versus-host disease. J Clin Invest 112:1880-1886, 2003 DOI |
29 | Chu Y-W, Gress RE: Murine models of chronic graft-versus- host disease: insights and unresolved issues. Biol Blood Marrow Transplant 14:365-378, 2008 DOI ScienceOn |
30 | Murphy WJ: Revisiting graft-versus-host disease models of autoimmunity: new insights in immune regulatory processes. J Clin Invest 106;745-747, 2000 DOI ScienceOn |
31 | Welniak LA, Blazar BR, Murphy WJ: Immunobiology of allogeneic hematopoietic stem cell transplantation. Annu Rev Immunol 25;139-170, 2007 DOI ScienceOn |
32 | Kim J, Park K, Kim HJ, Kim J, Kim H-A, Jung D, Kim HJ, Choi H-J, Choi S-K, Suh K, Cho HR, Kwon B: Breaking of T cell tolerance through in vivo ligation of CD40 results in inhibition of chronic graft-versus-host disease and complete donor cell engraftment. J Immunol 181;7380- 7389, 2008 |
33 | Via CS, Sharrow SO, Shearer GM: Role of cytotoxic T lymphocytes in the prevention of lupus-like disease disease occurring in a murine model of graft-vs-host disease. J Immunol 139;1840-1849, 1987 |
34 | Rus V, Svetic A, Nguyen P, Gause WC, Via CS: Kinetics of Th1 and Th2 cytokine production during the early course of acute and chronic murine graft-versus-host disease. J Immunol 155;2396-2406, 1995 |
35 | Kim J, Choi WS, Kang H, Kim HJ, Suh J-H, Sakguchi S, Kwon B: Conversion of alloantigen-specific T cell anergy to T cell priming through in vivo ligation of glucocorticoid-induced TNF receptor. J Immunol 176; 5223-5231, 2006 |
36 | Via CS, Finkelman FD: Critical role of interleukin-2 in the development of acute graftversus-host disease. Int Immunol 5;565-572, 1993 DOI ScienceOn |
37 | Shustov A, Luzina I, Nguyen P, Papadimitriou JP, Handwerger B, Elkon KB, Via CS: Role of perforin in controlling B-cell hyperactivity and humoral autoimmunity. J Clin Invest 106;R39-47, 2000 DOI ScienceOn |
38 | Via CS, Shustov A, Rus V, Lang T, Nguyen P, Finkelman FD: In vivo neutralization of TNF- promotes humoral autoimmunity by preventing the induction of CTL. J Immunol 167;6821-6826, 2001 DOI |
39 | Kim J, Choi WS, La S, Suh J-H, Kim B-S, Cho HR, Kwon BS, Kwon B: Stimulation with 4-1BB inhibits chronic graft-versus-host disease by inducing activation-induced cell death of donor T cells. Blood 105:2206-2213, 2005 DOI ScienceOn |